Dyslexia Treatment Market

Increasing prevalence of Dyslexia to Boost the Market Growth

Dyslexia is a specific learning disability that is neurobiological in origin. It is characterized by difficulties with accurate and/or fluent word recognition and by poor spelling and decoding abilities. Worldwide statistics emphasize that one in ten people will have dyslexia. Somewhere between 25-40% of children with dyslexia also have attention deficit hyperactivity disorder (ADHD) and conversely, approximately 25% of children with ADHD also have dyslexia.

Similarly, according to Dystech (Australia), a science-based company publishing scientific research papers, the large patient pool suffering from dyslexia in developed nations is complemented by an increasing number of children suffering from the condition in developing countries. For instance, an article published in September 2020 in the International Journal of Environmental Research and Public Health titled “The Prevalence of Dyslexia in Primary School Children and Their Chinese Literacy Assessment in Shantou, Guangdong, China” enrolled a total of 2,955 students aged 7–12 years through randomized cluster sampling.

The prevalence rate of children with dyslexia was 5.4% in Shantou, 8.4% in boys, and 2.3% in girls.

Thus, a large population suffering from learning disabilities prone to developing dyslexia is adding up a number of patients with dyslexia. Additionally, an increasing number of learning programs focused on dyslexia is helping the growth of the dyslexia treatment & diagnosis market. For example, non-profit organizations such as The African Dyslexia Organization is raising donations for “Free dyslexia diagnosis children fund” and increasing awareness about dyslexia in the region. An increase in the level of awareness in developing regions about dyslexia is expected to increase the diagnosis rate during the forecast period.

The graph that follows illustrates the prevalence rate of dyslexia in males and females. The percentage of dyslexia in 3rd-grade boys and girls was 71.4% and 28.6%. Similarly, the percentages were 80.4% and 19.6%, 71.9% and 28.1%, and 75% and 25% in the 4th, 5th, and 6th grades respectively.

The growing awareness surrounding dyslexia and its impact on learning is a primary driver of the Global Dyslexia Treatment Market Industry. Educational institutions and parents are increasingly recognizing the need for early diagnosis and intervention. This heightened awareness leads to a greater demand for specialized treatment programs and resources. As a result, the market is projected to reach 31.4 USD Billion in 2024, reflecting a significant shift towards prioritizing dyslexia support. Furthermore, initiatives by governments and educational bodies to promote understanding of dyslexia contribute to this trend, fostering an environment where effective treatments can flourish.

Government initiatives aimed at improving educational outcomes for individuals with dyslexia significantly influence the Global Dyslexia Treatment Market Industry. Various countries are implementing policies that allocate funding for dyslexia research and treatment programs. For example, the establishment of national guidelines for dyslexia screening and intervention has led to increased investment in specialized training for educators. This proactive approach not only enhances the quality of treatment available but also raises public awareness about dyslexia. As a result, the market is expected to grow at a CAGR of 7.1% from 2025 to 2035, reflecting the positive impact of these initiatives on treatment accessibility.

Technological innovations play a crucial role in shaping the Global Dyslexia Treatment Market Industry. The integration of digital tools, such as mobile applications and online platforms, enhances the accessibility and effectiveness of dyslexia interventions. For instance, software that utilizes artificial intelligence to tailor learning experiences to individual needs is gaining traction. This trend is likely to drive market growth, as more families and educators adopt these technologies. The anticipated growth from 31.4 USD Billion in 2024 to 66.7 USD Billion by 2035 indicates a robust demand for tech-driven solutions in dyslexia treatment, suggesting a paradigm shift in how dyslexia is approached.

The shift towards personalized learning approaches in education is reshaping the Global Dyslexia Treatment Market Industry. Tailoring educational strategies to meet the unique needs of individuals with dyslexia enhances engagement and improves learning outcomes. This trend is supported by research indicating that personalized interventions can significantly reduce the challenges faced by dyslexic learners. As educational systems worldwide adopt these methodologies, the demand for specialized dyslexia treatments is expected to rise. The market's growth trajectory, projected at a CAGR of 7.1% from 2025 to 2035, reflects the increasing recognition of the importance of personalized learning in addressing dyslexia.

The increasing prevalence of learning disabilities, including dyslexia, is a significant driver of the Global Dyslexia Treatment Market Industry. Recent statistics indicate that approximately 5-10% of the global population is affected by dyslexia, necessitating effective treatment solutions. This rising incidence prompts educational institutions and healthcare providers to seek comprehensive treatment options, thereby expanding the market. The projected growth from 31.4 USD Billion in 2024 to 66.7 USD Billion by 2035 underscores the urgency for targeted interventions. As awareness of learning disabilities continues to grow, the demand for specialized dyslexia treatments is likely to increase, further propelling market expansion.

By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. North America dyslexia treatment held the largest market share in 2022. This is attributed to the developed healthcare infrastructure, favorable government policies, presence of major key companies headquarters in the region such as Jubilant Cadista (US) and Speechify (US), and the high prevalence of dyslexia are driving the market in the region.

Moreover, there are several not-for-profit organizations based in the region with a presence. These organizations increase awareness regarding dyslexia and provide support to patients and their families.

Further, the major countries studied are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Europe dyslexia treatment market accounts for the second-largest market share due to the increasing prevalence of dyslexia rapid technological advancements, and shorter procedure time are among other factors driving the market in Europe. Further, the Germany dyslexia treatment market held the largest market share, and the UK dyslexia treatment market was the fastest-growing market in the European region.

The Asia-Pacific dyslexia treatment market is expected to grow at a significant growth rate during the forecast period. This is due to the presence of several market players and increasing disposable income. Moreover, China dyslexia treatment market held the largest market share, and the India dyslexia treatment market was the fastest-growing market in the Asia-Pacific region. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period.

Major market players are spending a lot of money on R&D to increase their product lines, which will help the dyslexia treatment market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the dyslexia treatment industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the dyslexia treatment industry to benefit clients and expand the dyslexia treatment market sector is to manufacture locally to reduce operating costs.

Lingit (Norway) is a Verdane-owned software company offering multilingual literacy support for dyslexics and others with reading and writing difficulties. The company's dyslexia aid software makes reading and writing easier by assisting with spelling, vocabulary, and reading in text processing programs for computers and tablets, enabling users with multilingual support to avoid reading and writing errors. In October 2020, Lingit AS acquired Claro Software Ltd, a UK-based software company that offers multi-platform software for reading and writing support. With this acquisition, Lingit took its first international step in the industry.